Healthcare Sector

MRK

Market Tracker

$89.76
+0.53
(+0.59%)
4:00 am
Next Earnings: (est.) 08/01/23 12:00 am
  • MRK (Selected)

    Merck & Co., Inc.
  • MRK#

    Merck & Co., Inc. (MRK
  • MRKR

    Marker Therapeutics, Inc.

MRK Support / Resistance Levels

Loading Data..
WhaleStream

15m Chart - Support and Resistance levels are based on the large dark pool & equity prints at the plotted levels. Displays strongest levels above and below the spot price.

MRK Most Active Options Strike Prices Whale BUY Activity - 5 day

Loading Data..

Represents the strikes that had the highest premium of whale flow (on the ASK side) over the past 5 trading days.

MRK Most Active Options Strike Prices Whale SALES Activity - 5 day

Loading Data..

Represents the strikes that had the highest premium of whale flow (on the BID side) over the past 5 trading days.

MRK Dark Pool and Public Equity Key Price Levels

Loading Data..

Represents the largest cumulative premium levels above and below the current spot price. The price in the pink bubble represents the spot price.

MRK Open Interest Trend

Loading Data..

Total Open Interest of Calls & Puts across all strikes and expirations over the past 16 trading days.

MRK Largest 1-Day Open Interest Movements

Expires Type Strike OI Change Percent
04/11/2025 PUT $89.00 3,331 +3,209 +2,630.33%
04/04/2025 CALL $89.00 1,393 +1,297 +1,351.04%
04/25/2025 CALL $95.00 952 +825 +649.61%
04/04/2025 PUT $89.00 1,831 +667 +57.30%
04/04/2025 CALL $90.00 6,958 +574 +8.99%
09/19/2025 CALL $90.00 1,552 +537 +52.91%
01/16/2026 CALL $80.00 862 -75 -8.00%
04/17/2025 CALL $115.00 2,323 -84 -3.49%
04/11/2025 PUT $85.00 1,181 -92 -7.23%
06/20/2025 CALL $65.00 115 -114 -49.78%
04/17/2025 CALL $89.00 1,342 -165 -10.95%
04/17/2025 PUT $86.00 2,985 -275 -8.44%

Contracts with largest changes in open interest from the previous trading day to the current/most recent.

MRK Major Holders

Name Pct Held Shares Total
Vanguard Total Stock Market Index Fund 3.04% 77.07M 8.28B
Vanguard 500 Index Fund 2.31% 58.61M 6.3B
Fidelity 500 Index Fund 1.09% 27.79M 2.99B
SPDR S&P 500 ETF Trust 1.08% 27.45M 2.95B
iShares Core S&P 500 ETF 0.89% 22.63M 2.43B
Vanguard Index-Value Index Fund 0.86% 21.91M 2.35B
Select Sector SPDR Fund-Health Care 0.81% 20.59M 2.21B
Vanguard Specialized-Health Care Fund 0.72% 18.31M 1.97B
Vanguard Institutional Index Fund-Institutional Index Fund 0.70% 17.77M 1.91B
Schwab Strategic Tr-Schwab U.S. Dividend Equity ETF 0.68% 17.38M 1.87B

MRK News

  • Deadline Alert: Merck & Co (MRK) Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit

    03/31 12:00 pm

    GlobeNewswire Inc.

    Read more
  • Why Pfizer Is My Largest Healthcare Position

    03/27 06:45 am

    The Motley Fool

    Read more
  • Why Summit Therapeutics Stock Slipped Today

    03/26 05:21 pm

    The Motley Fool

    Read more
  • DEADLINE ALERT for ICLR, ESTC, FMC, MRK: Law Offices of Howard G. Smith Reminds Investors of Opportunity to Lead Securities Fraud Class Actions

    03/26 12:00 pm

    GlobeNewswire Inc.

    Read more
  • Why Pharma and Biotech Stocks Got Thrashed on Tuesday

    03/25 06:47 pm

    The Motley Fool

    Read more
  • Analyst Initiates Coverage On 'Undervalued' Summit Therapeutics

    03/24 02:17 pm

    Benzinga

    Read more
  • SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Merck & Co.

    03/23 08:46 am

    GlobeNewswire Inc.

    Read more
  • Pharmaceutical Firms Say UK Investment Is 'Unlikely' Unless Payment Levy Is Adressed

    03/21 12:31 pm

    Benzinga

    Read more
  • The Gross Law Firm Reminds Merck Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of April 14, 2025 – MRK

    03/20 01:01 pm

    GlobeNewswire Inc.

    Read more
  • Deadline Alert: Merck & Co (MRK) Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit

    03/18 12:00 pm

    GlobeNewswire Inc.

    Read more
  • ROSEN, LEADING INVESTOR COUNSEL, Encourages Merck & Co., Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – MRK

    03/16 05:57 am

    GlobeNewswire Inc.

    Read more
  • Should You Buy the 3 Highest-Paying Dividend Stocks in the Dow Jones?

    03/16 05:20 am

    The Motley Fool

    Read more
  • Down 93%, Is It Finally Time to Buy Moderna?

    03/15 04:38 am

    The Motley Fool

    Read more
  • ROSEN, SKILLED INVESTOR COUNSEL, Encourages Merck & Co., Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – MRK

    03/13 06:59 pm

    GlobeNewswire Inc.

    Read more
  • Bioengineered Protein Drugs Market Size to Cross USD 672.7 Billion by 2034, Growing at a CAGR of 6.2% - Report by Transparency Market Research, Inc.

    03/13 06:00 pm

    GlobeNewswire Inc.

    Read more
  • This Could Be the Catalyst That Sends Summit Therapeutics' Stock Higher This Year

    03/13 07:30 am

    The Motley Fool

    Read more
  • Merck Plans Regulatory Submission For Two-Drug Regime For HIV Infection By Mid-2025

    03/12 01:30 pm

    Benzinga

    Read more
  • ROSEN, LEADING INVESTOR COUNSEL, Encourages Merck & Co., Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – MRK

    03/10 06:23 pm

    GlobeNewswire Inc.

    Read more
  • 3 Magnificent S&P 500 Dividend Stocks Down 20% to 63% to Buy and Hold Forever

    03/09 04:35 am

    The Motley Fool

    Read more
  • Is This Beaten-Down Artificial Intelligence (AI) Stock a Buy?

    03/08 11:02 am

    The Motley Fool

    Read more
  • 5 Top Stocks to Buy for March

    03/08 10:54 am

    The Motley Fool

    Read more
  • SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Merck & Co.

    03/08 08:52 am

    GlobeNewswire Inc.

    Read more
  • 3 Safe-Haven Stocks to Buy Amidst a Global Trade War

    03/05 10:35 am

    Investing.com

    Read more
  • ROSEN, A LEADING NATIONAL FIRM, Encourages Merck & Co., Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – MRK

    03/04 08:57 pm

    GlobeNewswire Inc.

    Read more
  • DEADLINE ALERT for ICLR, ESTC, FMC, MRK: Law Offices of Howard G. Smith Reminds Investors of Opportunity to Lead Securities Fraud Class Actions

    03/04 01:00 pm

    GlobeNewswire Inc.

    Read more
  • ROSEN, A LEADING LAW FIRM, Encourages Merck & Co., Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – MRK

    03/01 02:14 pm

    GlobeNewswire Inc.

    Read more
  • Merck & Co., Inc. Investors: Please contact the Portnoy Law Firm to recover your losses; April 14, 2025 Deadline to file Lead Plaintiff Motion

    02/27 04:53 pm

    GlobeNewswire Inc.

    Read more
  • Global Human Liver Model Market 2025-2030: Growth Driven by 3D Bioprinting & Liver Disease Research

    02/27 11:54 am

    GlobeNewswire Inc.

    Read more
  • Can Moderna's Aggressive Cost Cuts Help Turn Things Around for Its Stock?

    02/27 11:05 am

    The Motley Fool

    Read more
  • ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Merck & Co., Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – MRK

    02/26 08:00 pm

    GlobeNewswire Inc.

    Read more
  • DEADLINE ALERT for ICLR, ESTC, FMC, MRK: Law Offices of Howard G. Smith Reminds Investors of Opportunity to Lead Securities Fraud Class Actions

    02/26 01:00 pm

    GlobeNewswire Inc.

    Read more
  • LAG-3 Immunotherapies Market Set for Rapid Growth in the Coming 10 Years Across the 7MM as Next-Generation Therapies Advance | DelveInsight

    02/25 02:00 pm

    GlobeNewswire Inc.

    Read more
  • Evaxion extends phase 2 trial with personalized cancer vaccine EVX-01 to further enhance clinical data package

    02/25 09:00 am

    GlobeNewswire Inc.

    Read more
  • Questex’s Fierce Pharma Unveils the Conference Program for the Inaugural Fierce Pharma Engage, Over 100 Speakers Confirmed to Deliver Unparalleled Education

    02/24 11:00 am

    GlobeNewswire Inc.

    Read more
  • 3 Magnificent S&P 500 Dividend Stocks Down 36% to 64% to Buy and Hold Forever

    02/24 08:00 am

    The Motley Fool

    Read more
  • ROSEN, HIGHLY RECOGNIZED INVESTOR COUNSEL, Encourages Merck & Co., Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – MRK

    02/23 11:54 pm

    GlobeNewswire Inc.

    Read more
  • MERCK INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that Merck & Co., Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - MRK

    02/22 06:15 pm

    GlobeNewswire Inc.

    Read more
  • Hyperlipidemia Drugs Market Size to Promote USD 31.49 Bn by 2034

    02/21 11:00 am

    GlobeNewswire Inc.

    Read more
  • ROSEN, SKILLED INVESTOR COUNSEL, Encourages Merck & Co., Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – MRK

    02/20 05:50 pm

    GlobeNewswire Inc.

    Read more
  • BESREMi Achieves Strong Market Growth Amid Rising Demand for Polycythemia Vera Treatment

    02/20 02:00 pm

    GlobeNewswire Inc.

    Read more
  • Antibody-Drug Conjugates Market to Witness Rapid Growth Across 7MM During the Study Period (2020–2034) as New Innovations Drive Therapy Advancements | DelveInsight

    02/20 02:00 pm

    GlobeNewswire Inc.

    Read more
  • North America Leads the Beta-Glucan Boom: Market Insights & Industry Innovations

    02/19 09:45 pm

    GlobeNewswire Inc.

    Read more
  • MERCK & CO., INC. (NYSE: MRK) INVESTOR ALERT: Investors With Large Losses in Merck & Co., Inc. Should Contact Bernstein Liebhard LLP To Discuss Their Rights

    02/19 02:50 pm

    GlobeNewswire Inc.

    Read more
  • Merck & Co. Stockholder Notice: Shareholder Rights Law Firm Robbins LLP Reminds Investors of the Class Action Filed Against MRK

    02/18 09:09 pm

    GlobeNewswire Inc.

    Read more
  • Global Immune Checkpoint Inhibitors Market to Cross USD 100 Billion by 2032 | DelveInsight

    02/18 02:00 pm

    GlobeNewswire Inc.

    Read more
  • 3 Blue-Chip Dividend Stocks Trading at Multiyear Lows

    02/13 10:30 am

    The Motley Fool

    Read more
  • Respiratory Syncytial Virus Therapeutics Market to Hit USD 4.64 Billion by 2032, Growing at a 14.5% CAGR – SNS Insider

    02/13 10:00 am

    GlobeNewswire Inc.

    Read more
  • Want Decades of Passive Income? 2 Stocks to Buy Now and Hold Forever.

    02/13 07:35 am

    The Motley Fool

    Read more
  • MRK INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that Merck & Co., Inc. Investors with Substantial Losses Have Opportunity to Lead the Merck Class Action Lawsuit

    02/12 07:31 pm

    GlobeNewswire Inc.

    Read more
👀

Follow the Whales in real-time.

🎁

Take 50% OFF With Code: